Trade

with

Data not available

Open

-

Previous Close

-

Volume (Avg)

-

Day's Range

-

52Wk Range

-

Market Cap.

-

P/E Ratio (EPS

-

Dividend Rate (Yield )

0.62 (-%)

Beta

0.71

Shares Outstanding

196.52M

P/E Ratio (EPS)

- (5.56)

AdChoices
Financials
  • Income Statement
  • Balance Sheet
  • Cash Flow
Operating Income
1.73B
Operating Margin
35.13
Total Equity
-
Retained Earnings
-
Free Cashflow
-
Price/Cashflow
23.26
Ownership

Institutional Ownership

15.66%

Top 10 Institutions

7.86%

Mutual Fund Ownership

5.05%

Float

-

5% / Insider Ownership

0.20%

Corporate insiders or major stockholders reporting trading activity in the stock.

Top Mutual Fund Owners

Top Institutional Owners

Mutual Fund Name

Institution Name

  • Mutual Fund Name

  • Shares Held

  • % Change

  • % Outstanding

  • Fidelity® Select Health Care Portfolio

  •  

    1,280,000

  • -0.78

  • 0.66

  • Waddell & Reed Advisor Core Investment F

  •  

    633,600

  • 0.00

  • 0.32

  • iShares Nasdaq Biotechnology

  •  

    422,120

  • 3.08

  • 0.15

  • Fidelity® Puritan® Fund

  •  

    404,500

  • 0.00

  • 0.21

  • Franklin Biotechnology Discovery

  •  

    322,100

  • 44.57

  • 0.16

  • Fidelity Advisor® Health Care Fund

  •  

    282,300

  • 2.54

  • 0.15

  • Fidelity® Select Pharmaceuticals Port

  •  

    271,500

  • -3.31

  • 0.14

  • Fidelity® Blue Chip Growth Fund

  •  

    209,559

  • 30.44

  • 0.11

  • Vanguard Morgan™ Growth Fund

  •  

    196,831

  • -8.08

  • 0.10

  • BlackRock Health Sciences Opps Port

  •  

    196,400

  • 0.00

  • 0.10

  • Institution Name

  • Shares Held

  • % Change

  • % Outstanding

  • Fidelity Management and Research Company

  •  

    3,409,259

  • +54.86%

  • 1.71

  • Paulson & Company Inc

  •  

    3,366,539

  • +33.07%

  • 1.69

  • Waddell & Reed Investment Management Co

  •  

    2,295,669

  • -0.77%

  • 1.15

  • Arrowstreet Capital Limited Partnership

  •  

    1,311,415

  • -10.90%

  • 0.66

  • Eaton Vance Management

  •  

    1,072,965

  • -13.36%

  • 0.54

  • Invesco Advisers, Inc

  •  

    918,266

  • -5.51%

  • 0.46

  • Orbimed Advisors, LLC

  •  

    905,200

  • +54.21%

  • 0.45

  • Goldman Sachs Asset Management, L.P.

  •  

    865,588

  • -17.79%

  • 0.43

  • Pnc Bank, National Association

  •  

    862,611

  • -2.75%

  • 0.43

  • Renaissance Technologies Corp

  •  

    675,575

  • +20.27%

  • 0.34

Company Profile

Sector

Healthcare

Industry

Biotechnology

Type

Classic Growth

Style

Large Growth

Shire PLC was registered in Jersey on 28th January, 2008. It is a specialty biopharmaceutical company that focuses on developing and marketing specialty medicines that address significant unmet patient needs. The Company unified its ...morebusiness during 2013 by integrating the operations of the Specialty Pharmaceuticals (SP), Human Genetic Therapies (HGT) and Regenerative Medicine (RM) business units into a simplified One Shire organization. The Company has four commercial units that focus exclusively on the commercial execution of its In-Line products in the following specialist therapeutic areas: Rare Diseases, Neuroscience, Gastrointestinal (GI) and Internal Medicine. The clinical development, manufacturing and marketing of the Company’s products is subject to governmental regulation in the US, the EU...more and other territories.lessless

Key People

Dr. Flemming Ornskov

CEO

Ms. Susan Kilsby

Chairman of the Board/Director

James Bowling

CFO

Dr. Steven Gillis PhD

Director

Mr. David Stout

Director

  • Shire PLC

  • 5 Riverwalk

  • Dublin, 24

  • JEY.Map

  • Phone: +353 14297700

  • Fax: -

  • shire.com

Incorporated

2008

Employees

5,338

Send Feedback

We appreciate your input!

  • I'm having trouble signing into my Microsoft account

  • I’m having problems with the services stripe (Mail, Facebook, etc.)

  • There is an issue with my weather information

  • I see an error in the content

  • Other

Please give an overall site rating: